Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3821063 | 0.96 | CYP3A4 (0.71) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 | |
| SCHEMBL6868292 | 0.96 | CYP3A4 (0.71) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 | |
| SCHEMBL3816600 | 0.92 | CYP3A4 (0.50) | CYP3A4TSHRL3MBTL1TRPM8 | |
| SCHEMBL4630569 | 0.90 | CYP3A4 (0.61) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 | |
| SCHEMBL6895750 | 0.89 | CYP3A4 (0.59) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 | |
| SCHEMBL1724998 | 0.85 | CYP3A4 (0.90) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL29001746 | 0.85 | CYP3A4 (0.90) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL575928 | 0.85 | CYP3A4 (0.90) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL17467186 | 0.85 | CYP3A4 (0.55) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 | |
| SCHEMBL6896841 | 0.84 | CYP3A4 (0.53) | CYP3A4TSHRL3MBTL1LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131530-A1 | A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF | BASF COATINGS GMBH (DE) | 2023-07-13 | — | — | WO | disclosed |
| US-20150376143-A1 | Prodrugs of NH-Acidic Compounds | ALKERMES PHARMA IRELAND LTD (IE) | 2015-12-31 | — | — | US | disclosed |
| US-8741809-B2 | Liquid pyraclostrobin-containing crop protection formulations | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20110195846-A1 | Liquid Pyraclostrobin-Containing Crop Protection Formulations | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2346322-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040835-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376143-A1 | Prodrugs of NH-Acidic Compounds | SI, NAAA, NIT2 | CYP3A4 733/4885TSHR 3738/4885L3MBTL1 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.